Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials in Spain and internationally. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter (OTC) drugs, food supplements, baby foods, and other health products. It offers Actimag, a magnesium pidolate; Bilaxten, an anti-allergic; Bronquidiazina CR, an anti-infective; Claversal for ulcerative colitis and Crohn's disease; Dezacor, a corticoid; Dolotren, an anti-inflammatory; Dolotren Gel; Dynamogen, an anti-anorexic; Ferroprotina, an anti-anaemic; Hidroferol; Lipofen; Positon for dermatitis; strength builder products, such as Potenciator and Surmenalit; Pruina, a laxative; Robaxisal Compuesto, a muscle relaxant and analgesic; Trausan, a citicoline; Venosmil, a venous vasoprotector; Venosmil Gel; and Yendol, an anti-flu. The company also provides Bilastine, an antihistamine molecule for the treatment of allergic rhino conjunctivitis and urticarial; Calcifediol for bone metabolism; Deflazacort to treat osteoarticular disease; Hidrosmin for venous insufficiency; and Mesalazine to treat digestion problems. It also exports its products. Faes Farma, S.A. was founded in 1933 and is headquartered in Leioa, Spain.
Faes Farma Dividend Announcement
• Faes Farma announced a semi annually dividend of €0.12 per ordinary share which will be made payable on 2024-07-08. Ex dividend date: 2024-07-04
• Faes Farma annual dividend for 2024 was €0.15
• Faes Farma annual dividend for 2023 was €0.16
• Faes Farma's trailing twelve-month (TTM) dividend yield is 4.33%
• Faes Farma's payout ratio for the trailing twelve months (TTM) is 10.25%
• Faes Farma's dividend growth over the last five years (2018-2023) was 6.21% year
• Faes Farma's dividend growth over the last ten years (2013-2023) was -0.03% year
Faes Farma Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-07-04 | €0.12 | semi annually | 2024-07-08 |
2024-01-11 | €0.04 | semi annually | 2024-01-15 |
2023-04-12 | €0.12 | semi annually | 2023-04-28 |
2023-01-05 | €0.04 | semi annually | 2023-01-09 |
2022-06-28 | €0.04 | semi annually | 2022-06-30 |
2021-12-16 | €0.17 | semi annually | 2021-12-23 |
2021-06-23 | €0.03 | semi annually | 2021-06-25 |
2020-12-16 | €0.17 | semi annually | 2020-12-23 |
2020-06-30 | €0.03 | semi annually | 2020-07-02 |
2019-12-16 | €0.14 | semi annually | 2020-01-02 |
2019-06-28 | €0.02 | semi annually | 2019-07-02 |
2018-12-14 | €0.12 | semi annually | 2018-12-21 |
2017-12-15 | €0.20 | semi annually | 2017-12-22 |
2017-06-16 | €0.04 | semi annually | 2017-06-20 |
2016-12-16 | €0.18 | semi annually | |
2016-06-28 | €0.03 | semi annually | |
2015-12-21 | €0.15 | semi annually | |
2015-07-01 | €0.03 | semi annually | |
2014-12-19 | €0.13 | semi annually | |
2014-06-06 | €0.06 | semi annually | |
2013-12-27 | €0.08 | semi annually | |
2013-06-06 | €0.08 | semi annually |
Faes Farma Dividend per year
Faes Farma Dividend growth
Faes Farma Dividend Yield
Faes Farma current trailing twelve-month (TTM) dividend yield is 4.33%. Interested in purchasing Faes Farma stock? Use our calculator to estimate your expected dividend yield:
Faes Farma Financial Ratios
Faes Farma Dividend FAQ
Other factors to consider when evaluating Faes Farma as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Faes Farma stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Faes Farma's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Faes Farma publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Faes Farma distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Faes Farma are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Faes Farma sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Faes Farma distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Faes Farma declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Faes Farma's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Faes Farma's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.